Insider Transactions in Q3 2025 at New Amsterdam Pharma CO N.V. (NAMS)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 16
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
51,043
-53.71%
|
$1,071,903
$21.1 P/Share
|
|
Jul 16
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,043
+34.94%
|
$510,430
$10.9 P/Share
|
|
Jul 15
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
47,569
-27.77%
|
$998,949
$21.75 P/Share
|
|
Jul 15
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,569
+34.19%
|
$475,690
$10.9 P/Share
|